Subjects sometimes desire to participate in medical trials that seem to have adverse risk-benefit ratios for them.  Why do they desire to participate, and is it ethically permissible to allow them to do so?  In 'Why high-risk, non-expected-utility-maximizing gambles can be rational and beneficial: The case of HIV cure studies', I apply my recent work on risk to both of these questions.